Rapid elevation of biogenic amine metabolites in human CSF following probenecid.
D000284:Administration, Oral; D000342:Affective Symptoms / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D005260:Female; D006261:Headache; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D008691:Methadone / Q000494:pharmacology; D009325:Nausea / Q000139:chemically induced; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000009:adverse effects / Q000494:pharmacology*; D013129:Spinal Puncture / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid; D008691:Methadone